TY - JOUR
T1 - Accurate determination for lipidomics based on LC-tandem-MS parameters modeling, prediction, and database
T2 - Monitoring the progression of hepatocellular carcinoma
AU - Zhang, Qian
AU - Tong, Minghui
AU - Xu, Huarong
AU - Yin, Yidi
AU - Gao, Peng
AU - Bi, Kaishun
AU - Zhang, Yiwen
AU - Li, Qing
N1 - Funding Information:
This study was supported by the National Natural Science Foundations of China (Grant No. 81973464/H3203 ; Grant No. 82104379/H3203 ; Grant No. 82104126/H3410 ); China Postdoctoral Science Foundation ( 2020M680989 ); Liaoning Provincial Doctoral Research Start-up Fund Project for Qian Zhang ( 2020-BS-126 ); Provincial Doctoral Research Start-up Fund Project for Yiwen Zhang ( 2021-BS-132 ); Liaoning Distinguished Professor Project for Qing Li (2017); Liaoning BaiQianWan Talents Program in 2019 for Qing Li (A-37); Shenyang Science and Technology Innovation Project for Young and Middle-aged Talents ( RC190505 ); Basic Scientific Research Project of Higher Education Department of Liaoning Province ( LJKQZ2021033 ).
Publisher Copyright:
© 2022
PY - 2023/1/20
Y1 - 2023/1/20
N2 - The unavailability of adequate lipid reference standards is a major challenge for accurate quantitative analysis of lipidomics. Based on the discovery of regularity and predictability for lipids in chromatography-mass spectrometry behaviors, “target compound-structure correlation-analytical parameter database” protocol and “modeling-prediction” strategy were carried out to calculate the relative coefficients of analytical parameters within each subclass. Then the relevant LC-tandem-MS parameters of unknown lipids were predicted and a quantification parameter database for 4081 lipids was established and validated. Reference standards-independent accurate determination for lipidomics was achieved with the parameter's database and applied to monitor the change of lipid metabolism in the plasma of whole course of health-hepatitis-cirrhosis-hepatocellular carcinoma (HCC). Combined Student's t test, orthogonal partial least squares discrimination analysis (OPLS-DA) and binary logistic regression-ROC analysis, lipid biomarkers for differentiating health from each disease and differentiating different stages of disease were identified and the pathogenesis of HCC was preliminarily clarified. The established methodology would shed light on comprehensive and accurate quantitative lipidomics and exploring the pathomechanism and potential therapeutic targets of HCC.
AB - The unavailability of adequate lipid reference standards is a major challenge for accurate quantitative analysis of lipidomics. Based on the discovery of regularity and predictability for lipids in chromatography-mass spectrometry behaviors, “target compound-structure correlation-analytical parameter database” protocol and “modeling-prediction” strategy were carried out to calculate the relative coefficients of analytical parameters within each subclass. Then the relevant LC-tandem-MS parameters of unknown lipids were predicted and a quantification parameter database for 4081 lipids was established and validated. Reference standards-independent accurate determination for lipidomics was achieved with the parameter's database and applied to monitor the change of lipid metabolism in the plasma of whole course of health-hepatitis-cirrhosis-hepatocellular carcinoma (HCC). Combined Student's t test, orthogonal partial least squares discrimination analysis (OPLS-DA) and binary logistic regression-ROC analysis, lipid biomarkers for differentiating health from each disease and differentiating different stages of disease were identified and the pathogenesis of HCC was preliminarily clarified. The established methodology would shed light on comprehensive and accurate quantitative lipidomics and exploring the pathomechanism and potential therapeutic targets of HCC.
KW - Hepatocellular carcinoma
KW - Lipidomics
KW - “Modeling-prediction-database” strategy
UR - http://www.scopus.com/inward/record.url?scp=85140899428&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140899428&partnerID=8YFLogxK
U2 - 10.1016/j.jpba.2022.115126
DO - 10.1016/j.jpba.2022.115126
M3 - Article
C2 - 36327578
AN - SCOPUS:85140899428
VL - 223
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
SN - 0731-7085
M1 - 115126
ER -